Immunotargeting of insulin reactive CD8 T cells to prevent Diabetes

Wong, 1999, Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library, Nat Med, 5, 1026, 10.1038/12465 Lieberman, 2003, Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes, Proc Natl Acad Sci U S A, 100, 8384, 10.1073/pnas.0932778100 Lieberman, 2004, Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase, J Immunol, 173, 6727, 10.4049/jimmunol.173.11.6727 Quinn, 2001, MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity, J Immunol, 167, 1748, 10.4049/jimmunol.167.3.1748 Nakayama, 2005, Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice, Nature, 435, 220, 10.1038/nature03523 Jyothi, 2002, Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes, Nat Biotechnol, 20, 1215, 10.1038/nbt758 Margalit, 2003, Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells, Int Immunol, 15, 1379, 10.1093/intimm/dxg136 Mitsuyasu, 2000, Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects, Blood, 96, 785, 10.1182/blood.V96.3.785 Nguyen, 2003, Antigen-specific targeting of CD8+ T cells with receptor-modified T lymphocytes, Gene Ther, 10, 594, 10.1038/sj.gt.3301932 Wong, 1996, CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells, J Exp Med, 183, 67, 10.1084/jem.183.1.67 Wong, 2009, Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes, Diabetes, 58, 1156, 10.2337/db08-0800 Wong, 2002, Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus, Proc Natl Acad Sci U S A, 99, 5551, 10.1073/pnas.072037299 Lee-MacAry, 2001, Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide, J Immunol Methods, 252, 83, 10.1016/S0022-1759(01)00336-2 Thomas, 2007, CD86 has sustained costimulatory effects on CD8 T cells, J Immunol, 179, 5936, 10.4049/jimmunol.179.9.5936 Kataoka, 1994, Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity, J Immunol, 153, 3938, 10.4049/jimmunol.153.9.3938 Trudeau, 2003, Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood, J Clin Invest, 111, 217, 10.1172/JCI200316409 Krishnamurthy, 2006, Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP, J Clin Invest, 116, 3258, 10.1172/JCI29602 Brodie, 2008, B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes, Diabetes, 57, 909, 10.2337/db07-1256 Serreze, 1994, Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant, Diabetes, 43, 505, 10.2337/diabetes.43.3.505 Wicker, 1994, Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes, Diabetes, 43, 500, 10.2337/diabetes.43.3.500 Wang, 1996, The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus, Eur J Immunol, 26, 1762, 10.1002/eji.1830260815 Amrani, 2000, Progression of autoimmune diabetes driven by avidity maturation of a T-cell population, Nature, 406, 739, 10.1038/35021081 Toma, 2005, Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients, Proc Natl Acad Sci U S A, 102, 10581, 10.1073/pnas.0504230102 Hassainya, 2005, Identification of naturally processed HLA-A2–restricted proinsulin epitopes by reverse immunology, Diabetes, 54, 2053, 10.2337/diabetes.54.7.2053 Mallone, 2007, CD8+ T-cell responses identify {beta}-cell autoimmunity in human type 1 diabetes, Diabetes, 56, 613, 10.2337/db06-1419 Baker, 2008, Human CD8 responses to a complete epitope set from preproinsulin: implications for approaches to epitope discovery, J Clin Immunol, 10.1007/s10875-008-9177-4 Skowera, 2008, CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope, J Clin Invest, 118, 3390 Ou, 1999, CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility, Hum Immunol, 60, 652, 10.1016/S0198-8859(99)00037-3 Panina-Bordignon, 1995, Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes, J Exp Med, 181, 1923, 10.1084/jem.181.5.1923 Ouyang, 2006, Recognition of HLA class I-restricted beta-cell epitopes in type 1 diabetes, Diabetes, 55, 3068, 10.2337/db06-0065 Panagiotopoulos, 2003, Identification of a beta-cell-specific HLA class I restricted epitope in type 1 diabetes, Diabetes, 52, 2647, 10.2337/diabetes.52.11.2647 Standifer, 2006, Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives, Diabetes, 55, 3061, 10.2337/db06-0066